Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis

Схожие документы

• Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
  по: Richa Manwani, и др.
  Опубликовано: (2018-04-01)
• Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis
  по: Ashutosh D. Wechalekar, и др.
  Опубликовано: (2011-07-01)
• Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
  по: Sriram Ravichandran, и др.
  Опубликовано: (2021-06-01)
• Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
  по: Steven Law, и др.
  Опубликовано: (2020-12-01)
• Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients
  по: Jahanzaib Khwaja, и др.
  Опубликовано: (2024-01-01)